SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-677499
Filing Date
2016-08-10
Accepted
2016-08-10 07:10:32
Documents
3
Period of Report
2016-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d241217d8k.htm 8-K 17673
2 EX-99.1 d241217dex991.htm EX-99.1 62948
3 GRAPHIC g241217g0810011755825.jpg GRAPHIC 4127
  Complete submission text file 0001193125-16-677499.txt   87803
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 161819953
SIC: 2834 Pharmaceutical Preparations